FindTrial
Sign In

a study to search a suitable dose of a drug, dexmedetomidine for early onset and prolongation of anaesthesia in brachial plexus block.

Comparitive evaluation of two doses of dexmedetomidine added to levobupivicaine for brachial plexus block.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2016/04/006823
Enrollment
100
Registered
2016-04-13
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: dexmedetomidine 1ug/kg: dexmedetomidine 1 ug/kg added to 0.5% levobupivicaine 20 cc Control Intervention1: dexmedetomidine 2 ug/kg: dexmedetomidine 2ug/kg added to 20 cc 0.5% levobupivi

Sponsors

AIIMSPatna
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age : 18 to 60 years 2. ASA I and II 3. Posted for Forearm/ elbow surgeries

Exclusion criteria

Exclusion criteria: 1. ASA III or more 2. Bleeding / coagulation disorder 3. Uncontrolled diabetes/ HTN 4. Patients with heart blocks/ cardiac disease

Design outcomes

Primary

MeasureTime frame
duration of analgesia: time between the block and the first analgesic requirement(VAS4)Timepoint: pain will be assessed hourly after six hours till 24 hours—

Secondary

MeasureTime frame
1. duration of sensory blockade 2. duration of motor blockadeTimepoint: 1.block will be assessed hourly after surgery till 24 hours 2.motor blockade will be assessed hourly after the end of surgery till twenty four hours.;3.to study the effect on hemodynamics(heart rate and mean arterial pressure)Timepoint: every 15 minutes till three hours—

Countries

India

Contacts

Public Contactdr chandni sinha

assistant professor, Department of Anaesthesia

chandni.doc@gmail.com06122451205

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026